Jazz Pharmaceuticals Soaring 15%

Jazz Pharmaceuticals, Inc. JAZZ shares are soaring today, gaining more than 15% after the company reported earnings last night. The company reported earnings that beat Wall Street estimates and raised 2011 earnings estimates. The company said it expects to earn $2.68 to $2.79 per share in 2011 on revenues of $247-$260 million. Wall Street is expecting earnings of $2.68 per share on revenues of $255 million. Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States.